Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Parren, PW"'
Understanding the antibody response in HIV-1 infection is important to vaccine design. We have studied the antibody response to HIV-1 envelope at the molecular level and determined the characteristics of neutralizing and non-neutralizing antibodies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5feb079d2cb6faf222acd847c0c9c811
https://ora.ox.ac.uk/objects/uuid:5425328d-38a6-47f3-9173-5a11344d78cc
https://ora.ox.ac.uk/objects/uuid:5425328d-38a6-47f3-9173-5a11344d78cc
Autor:
Glorius P, Baerenwaldt A, Kellner C, Staudinger M, Dechant M, Stauch M, Beurskens FJ, Parren PW, Winkel JG, Valerius T, Humpe A, Repp R, Gramatzki M, Nimmerjahn F, Peipp M
Publikováno v:
Leukemia (08876924); Jan2013, Vol. 27 Issue 1, p190-201, 12p
Autor:
Gammelgaard OL; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Terp MG; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Renn C; PharmaCenter Bonn, Pharmaceutical Sciences Bonn (PSB), Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, Bonn, Germany., Labrijn AF; Genmab BV, Utrecht, The Netherlands., Hamaker O; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Nielsen AY; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Vever H; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Hansen SW; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Gjerstorff MF; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Oncology, Odense University Hospital, Odense, Denmark., Müller CE; PharmaCenter Bonn, Pharmaceutical Sciences Bonn (PSB), Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, Bonn, Germany., Parren PW; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Ditzel HJ; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark hditzel@health.sdu.dk.; Department of Oncology, Odense University Hospital, Odense, Denmark.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Sep; Vol. 10 (9).
Autor:
Koopman LA; Genmab, Utrecht, Netherlands., Terp MG; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Zom GG; Genmab, Utrecht, Netherlands., Janmaat ML; Genmab, Utrecht, Netherlands., Jacobsen K; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Gresnigt-van den Heuvel E; Genmab, Utrecht, Netherlands., Brandhorst M; Genmab, Utrecht, Netherlands., Forssmann U; Genmab, Utrecht, Netherlands., de Bree F; Genmab, Utrecht, Netherlands., Pencheva N; Genmab, Utrecht, Netherlands., Lingnau A; Genmab, Utrecht, Netherlands., Zipeto MA; Crown Bioscience San Diego, San Diego, California, USA., Parren PW; Genmab, Utrecht, Netherlands.; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands., Breij EC; Genmab, Utrecht, Netherlands., Ditzel HJ; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Oncology, Odense University Hospital, Odense, Denmark.
Publikováno v:
JCI insight [JCI Insight] 2019 Nov 01; Vol. 4 (21). Date of Electronic Publication: 2019 Nov 01.
Autor:
van de Donk NWCJ; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Casneuf T; Janssen Research& Development, Beerse, Belgium., Di Cara A; Quartz Bio, Geneva, Switzerland., Parren PW; Genmab, Utrecht, The Netherlands.; Department of Cancer and inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Immunohaematology and Blood Transfusion, Leiden University Medical Centre, Leiden, the Netherlands., Zweegman S; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., van Kessel B; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Lokhorst HM; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Usmani SZ; Levine Cancer Institute/Carolinas Healthcare System, Charlotte, NC, USA., Lonial S; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA., Richardson PG; Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Chiu C; Janssen Research& Development, Spring House, PA, USA., Mutis T; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Nijhof IS; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Sasser AK; Janssen Research& Development, Spring House, PA, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2019 Feb; Vol. 184 (3), pp. 475-479. Date of Electronic Publication: 2018 Feb 07.
Autor:
Matas-Céspedes A; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Vidal-Crespo A; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Rodriguez V; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Villamor N; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona, Spain., Delgado J; Department of Hematology, Hospital Clínic, Barcelona, Spain., Giné E; Department of Hematology, Hospital Clínic, Barcelona, Spain., Roca-Ho H; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, University of Barcelona, Barcelona, Spain., Menéndez P; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estadis Avançats (ICREA), Barcelona, Spain., Campo E; Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona, Spain., López-Guillermo A; Department of Hematology, Hospital Clínic, Barcelona, Spain., Colomer D; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona, Spain., Roué G; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Wiestner A; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Parren PW; Genmab, Utrecht, the Netherlands.; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands., Doshi P; Janssen R&D, Spring House, Pennsylvania., van Bueren JL; Genmab, Utrecht, the Netherlands., Pérez-Galán P; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. pperez@clinic.ub.es.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Mar 15; Vol. 23 (6), pp. 1493-1505. Date of Electronic Publication: 2016 Sep 16.
Autor:
Tammen A; Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Christian Albrechts University, 24105 Kiel, Germany., Derer S; Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Christian Albrechts University, 24105 Kiel, Germany.; Medical Department 1, University Hospital Schleswig-Holstein, 23538 Lübeck, Germany., Schwanbeck R; Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Christian Albrechts University, 24105 Kiel, Germany., Rösner T; Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Christian Albrechts University, 24105 Kiel, Germany., Kretschmer A; Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Christian Albrechts University, 24105 Kiel, Germany., Beurskens FJ; Genmab, 3584 Utrecht, the Netherlands; and., Schuurman J; Genmab, 3584 Utrecht, the Netherlands; and., Parren PW; Genmab, 3584 Utrecht, the Netherlands; and.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 Leiden, the Netherlands., Valerius T; Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Christian Albrechts University, 24105 Kiel, Germany; t.valerius@med2.uni-kiel.de.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2017 Feb 15; Vol. 198 (4), pp. 1585-1594. Date of Electronic Publication: 2017 Jan 06.
Autor:
Engelberts PJ; Genmab, 3584 CM Utrecht, the Netherlands., Voorhorst M; Genmab, 3584 CM Utrecht, the Netherlands., Schuurman J; Genmab, 3584 CM Utrecht, the Netherlands., van Meerten T; Department of Hematology, University Medical Center Groningen, 9713 GZ Groningen, the Netherlands., Bakker JM; Genmab, 3584 CM Utrecht, the Netherlands., Vink T; Genmab, 3584 CM Utrecht, the Netherlands., Mackus WJ; Genmab, 3584 CM Utrecht, the Netherlands., Breij EC; Genmab, 3584 CM Utrecht, the Netherlands., Derer S; Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, Christian Albrechts University, 24105 Kiel, Germany., Valerius T; Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, Christian Albrechts University, 24105 Kiel, Germany., van de Winkel JG; Genmab, 3584 CM Utrecht, the Netherlands.; Department of Immunology, University Medical Center Utrecht, 3584 EA Utrecht, the Netherlands., Parren PW; Genmab, 3584 CM Utrecht, the Netherlands; P.Parren@genmab.com.; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark; and.; Department of Hematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands., Beurskens FJ; Genmab, 3584 CM Utrecht, the Netherlands.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2016 Dec 15; Vol. 197 (12), pp. 4829-4837. Date of Electronic Publication: 2016 Nov 02.
Autor:
Larrick JW; a Panorama Research Institute and Velocity Pharmaceutical Development , South San Francisco , CA , USA., Alfenito MR; b EnGen Bio, Inc. , San Mateo , CA , USA., Scott JK; c Simon Fraser University , Burnaby , BC , Canada., Parren PW; d Genmab , Utrecht , the Netherlands.; e Leiden University Medical Center , Leiden , the Netherlands., Burton DR; f The Scripps Research Institute , La Jolla , CA , USA., Bradbury AR; g Los Alamos National Laboratory , Los Alamos , NM , USA., Lemere CA; h Brigham and Woman's Hospital and Harvard Medical School , Boston MA , USA., Messer A; i Regenerative Research Foundation , Rensselaer , NY , USA., Huston JS; j Huston BioConsulting, LLC , Watertown , MA , USA., Carter PJ; k Genentech, Inc. , South San Francisco , CA , USA., Veldman T; l AbbVie , Worcester , MA , USA., Chester KA; m University College London , London , UK., Schuurman J; d Genmab , Utrecht , the Netherlands., Adams GP; n Viventia Bio, Inc. , Philadelphia , PA , USA., Reichert JM; o The Antibody Society , Framingham , MA , USA.
Publikováno v:
MAbs [MAbs] 2016 Nov/Dec; Vol. 8 (8), pp. 1425-1434. Date of Electronic Publication: 2016 Aug 24.
Autor:
de Goeij BE; Genmab, Utrecht, the Netherlands. BGO@genmab.com., Vink T; Genmab, Utrecht, the Netherlands., Ten Napel H; Genmab, Utrecht, the Netherlands., Breij EC; Genmab, Utrecht, the Netherlands., Satijn D; Genmab, Utrecht, the Netherlands., Wubbolts R; Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands., Miao D; Concortis Biosystems Corp., San Diego, California., Parren PW; Genmab, Utrecht, the Netherlands.; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2016 Nov; Vol. 15 (11), pp. 2688-2697. Date of Electronic Publication: 2016 Aug 24.